• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉注射可溶性IgG聚集体诱导大鼠C1q的体内降解

In vivo degradation of rat C1q induced by intravenous injection of soluble IgG aggregates.

作者信息

Veerhuis R, van Es L A, Daha M R

出版信息

Immunology. 1985 Apr;54(4):801-10.

PMID:3872261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1453567/
Abstract

Immune complexes are able to bind and activate the first component of complement, C1. Upon activation of C1, C1r and C1s are rapidly inactivated by C1-In which also forms a complex with these two subcomponents, resulting in their release from C1-immune aggregate complexes. The fate of C1q after the binding C1 to immune complexes in vivo is not clear and, therefore the clearance of radiolabelled rat C1q was investigated in normal rats and in rats receiving soluble aggregated human IgG. 125I-labelled rat C1q was cleared with a half-life (T 1/2) of 12.4 hr in normal rats. Injection of AIgG into rats that had previously received 125I-C1q accelerated the clearance of 125I-C1q, resulting, finally, in a T 1/2 of 53 min. The levels of circulating endogenous C1q were also followed using haemolytic titrations and immunochemical measurements. Directly after injection of AIgG into rats, there was a rapid decrease in C1q haemolytic activity to less than 25% of the initial value after 10 min. The rate of disappearance of C1q antigen, was, however, much slower, the lowest concentration being 30% at 2 hr. C1q haemolytic activity and the C1q antigen level returned to virtually normal values after 24 hr. Plasma samples were taken at different time intervals after the injection of AIgG and subjected to gel filtration on Sephacryl S-400 columns. It was found that, in the 10 min samples, C1q antigen and C1q haemolytic activity, each with an estimated molecular weight (MW) of 400,000, were detected together. In addition, there was C1q antigen with a MW of less than 69,000 without C1q haemolytic activity. SDS-PAGE analysis of the various serum samples indicated that the low MW C1q antigen had an apparent MW of 25,000. Measurement of uptake of 125I-C1q in various organs indicated that the main site of clearance of 125I-C1q is the liver.

摘要

免疫复合物能够结合并激活补体的第一成分C1。C1激活后,C1r和C1s会被C1抑制因子迅速灭活,C1抑制因子还会与这两个亚成分形成复合物,导致它们从C1 - 免疫聚集复合物中释放出来。体内C1q与免疫复合物结合后其命运尚不清楚,因此,研究了正常大鼠和接受可溶性聚集人IgG的大鼠中放射性标记的大鼠C1q的清除情况。在正常大鼠中,125I标记的大鼠C1q以12.4小时的半衰期(T1/2)被清除。给先前接受过125I - C1q的大鼠注射聚集人IgG(AIgG)加速了125I - C1q的清除,最终导致半衰期为53分钟。还使用溶血滴定和免疫化学测量来跟踪循环内源性C1q的水平。在给大鼠注射AIgG后,C1q溶血活性迅速下降,10分钟后降至初始值的不到25%。然而,C1q抗原的消失速度要慢得多,2小时时最低浓度为30%。24小时后,C1q溶血活性和C1q抗原水平几乎恢复到正常值。在注射AIgG后的不同时间间隔采集血浆样本,并在Sephacryl S - 400柱上进行凝胶过滤。发现在10分钟的样本中,检测到了估计分子量(MW)为400,000的C1q抗原和C1q溶血活性。此外,存在分子量小于69,000且无C1q溶血活性的C1q抗原。对各种血清样本的SDS - PAGE分析表明,低分子量C1q抗原的表观分子量为25,000。对125I - C1q在各种器官中的摄取测量表明,125I - C1q清除的主要部位是肝脏。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fded/1453567/4d55fe36e29a/immunology00197-0194-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fded/1453567/da64addac382/immunology00197-0190-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fded/1453567/4d55fe36e29a/immunology00197-0194-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fded/1453567/da64addac382/immunology00197-0190-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fded/1453567/4d55fe36e29a/immunology00197-0194-a.jpg

相似文献

1
In vivo degradation of rat C1q induced by intravenous injection of soluble IgG aggregates.静脉注射可溶性IgG聚集体诱导大鼠C1q的体内降解
Immunology. 1985 Apr;54(4):801-10.
2
Possible mechanisms of degradation of C1q in vivo and in vitro: role of macrophages.
Behring Inst Mitt. 1989 Jul(84):42-6.
3
Effects of soluble aggregates of IgG on the binding, uptake and degradation of the C1q subcomponent of complement by adherent guinea pig peritoneal macrophages.免疫球蛋白G可溶性聚集体对豚鼠腹膜黏附巨噬细胞结合、摄取和降解补体C1q亚成分的影响。
Eur J Immunol. 1985 Sep;15(9):881-7. doi: 10.1002/eji.1830150904.
4
The interaction of human plasma fibronectin with a subunit of the first component of complement, C1q.人血浆纤连蛋白与补体第一成分C1q的一个亚基之间的相互作用。
J Immunol. 1982 May;128(5):2036-9.
5
Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.针对补体亚成分C1q不同结构域的单克隆抗体对人补体第一成分C1的激活作用。
J Immunol. 1986 Jul 1;137(1):255-62.
6
The relationship between the binding ability and the rate of activation of the complement component C1.补体成分C1的结合能力与激活速率之间的关系。
Immunology. 1980 Sep;41(1):179-85.
7
Complement enhances the elimination of soluble aggregates of IgG by rat liver endothelial cells in vivo.
Eur J Immunol. 1993 Feb;23(2):433-8. doi: 10.1002/eji.1830230220.
8
The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro.补体亚成分C1q在体外介导免疫复合物和聚集体与内皮细胞的结合。
Eur J Immunol. 1988 May;18(5):783-7. doi: 10.1002/eji.1830180519.
9
Activation of C1 by soluble IgG aggregates as detected by a novel one-step hemolytic assay that specifically measures the proenzyme form of C1s.通过一种新型一步溶血试验检测可溶性IgG聚集体对C1的激活,该试验专门测量C1s的酶原形式。
J Immunol. 1983 Oct;131(4):1924-9.
10
C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.C1解离。人血清中自发产生一种三聚体复合物,其包含C1灭活剂、活化的C1r和C1s酶原。
J Immunol. 1987 Dec 15;139(12):4145-51.

引用本文的文献

1
Significance of low molecular weight C1q in systemic lupus erythematosus.低分子量C1q在系统性红斑狼疮中的意义。
Ann Rheum Dis. 1990 Sep;49(9):698-704. doi: 10.1136/ard.49.9.698.

本文引用的文献

1
Chromatographic resolution of the first component of human complement into three activities.将人类补体的第一成分通过色谱法分离为三种活性。
J Exp Med. 1963 Jun 1;117(6):983-1008. doi: 10.1084/jem.117.6.983.
2
Isolation of a thermolabile serum protein which precipitates gamma-globulin aggregates and participates in immune hemolysis.一种热不稳定血清蛋白的分离,该蛋白可沉淀γ-球蛋白聚集体并参与免疫溶血。
Proc Soc Exp Biol Med. 1961 Feb;106:291-5. doi: 10.3181/00379727-106-26313.
3
Analysis of receptor-mediated C1q binding to human peripheral blood mononuclear cells.
受体介导的C1q与人类外周血单个核细胞结合的分析。
J Immunol. 1980 Oct;125(4):1658-64.
4
Purification and radiolabeling of human C1q.人C1q的纯化与放射性标记
J Immunol. 1981 Aug;127(2):648-53.
5
Influence of aggregate size on the binding and activation of the first component of human complement by soluble IgG aggregates.聚集体大小对可溶性IgG聚集体与人补体第一成分的结合及激活的影响。
Immunology. 1982 Apr;45(4):705-13.
6
Activation of C1 by soluble IgG aggregates as detected by a novel one-step hemolytic assay that specifically measures the proenzyme form of C1s.通过一种新型一步溶血试验检测可溶性IgG聚集体对C1的激活,该试验专门测量C1s的酶原形式。
J Immunol. 1983 Oct;131(4):1924-9.
7
Characterization of a non-functional form of C1q found in patients with a genetically linked deficiency of C1q activity.在与C1q活性基因连锁缺陷患者中发现的无功能形式C1q的特征描述。
Mol Immunol. 1983 Oct;20(10):1117-25. doi: 10.1016/0161-5890(83)90121-9.
8
SLE like syndrome and functional deficiency of C1q in members of a large family.一个大家族成员中的系统性红斑狼疮样综合征及C1q功能缺陷
Clin Exp Immunol. 1984 Jan;55(1):106-14.
9
Dissociation of C1 and concentration dependence of its activation kinetics.C1的解离及其活化动力学的浓度依赖性。
Mol Immunol. 1982 May;19(5):683-91. doi: 10.1016/0161-5890(82)90370-4.
10
Activation of a complex of C1r and C1s subcomponents of human complement C1 by the third subcomponent C1q.人补体C1的第三亚成分C1q激活C1r和C1s亚成分的复合物。
J Biol Chem. 1980 Aug 25;255(16):7756-62.